Fresenius Kabi Oncology Ltd. clinical trials
Acquired by Fresenius Kabi, 2008 · source ↗
The registry lists 1 studies whose lead sponsor is Fresenius Kabi Oncology Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 8, 2010.
Before and after it joined Fresenius Kabi
- First submitted before Fresenius Kabi Oncology Ltd. became part of Fresenius Kabi
- 0
- First submitted after Fresenius Kabi Oncology Ltd. became part of Fresenius Kabi
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Fresenius Kabi Oncology Ltd.1 study
Something wrong with this grouping? Tell us on the Fresenius Kabi page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Fresenius Kabi studies →
- A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast CancerStatus unknownNCT00915369Phase 1
Sponsor listed in the registry: Fresenius Kabi Oncology Ltd. · First submitted after Fresenius Kabi Oncology Ltd. became part of Fresenius Kabi